We Do Care Weight Loss

We Do Care Weight Loss operates as a telehealth-focused weight management clinic serving patients throughout Las Vegas, Nevada, and surrounding regions. Under the medical direction of Dr. Michael Hansen, a board-certified physician in Internal Medicine, Pulmonary Disease, and Critical Care Medicine, the clinic provides prescription access to glucagon-like peptide-1 (GLP-1) receptor agonist medications as part of structured obesity management programs. The clinic's virtual care model eliminates geographic barriers for Nevada residents seeking medical weight loss support without the need for in-person office visits.

The treatment protocol centers on two FDA-approved GLP-1 medications: semaglutide and tirzepatide. Semaglutide functions by mimicking the GLP-1 hormone to regulate appetite and slow gastric emptying, while tirzepatide activates both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors for dual-pathway metabolic effects. Dr. Hansen evaluates patient medical histories, current health conditions, and weight loss objectives to determine appropriate medication selection and dosing schedules. The clinic provides ongoing prescription management with dosage adjustments based on patient response and tolerance. Nutritional guidance accompanies the pharmaceutical intervention, addressing dietary patterns that support sustained weight reduction while patients use these appetite-regulating medications.

Dr. Hansen brings extensive clinical experience from his triple board certifications, which provide a foundation for managing patients with complex medical backgrounds including metabolic syndrome, sleep-disordered breathing, and cardiovascular risk factors that frequently accompany obesity. His training in critical care and pulmonary medicine informs his approach to patients who may have obesity-related comorbidities such as obstructive sleep apnea or obesity hypoventilation syndrome. This background allows the clinic to serve patients whose weight management needs intersect with respiratory and systemic health concerns, though the primary clinical focus remains medical weight loss through GLP-1 therapy.

Patients initiate care through a telehealth consultation conducted via secure video platform, during which Dr. Hansen reviews medical history, current medications, previous weight loss attempts, and contraindications to GLP-1 therapy. The virtual format requires patients to have reliable internet access and the ability to participate in video appointments from their Las Vegas-area location. Following the initial assessment, patients receive electronic prescriptions sent to their preferred pharmacy, along with injection technique instructions for the subcutaneous administration required by both semaglutide and tirzepatide. Follow-up consultations occur at intervals determined by the treatment plan, typically aligning with dosage escalation phases and monitoring for adverse effects such as gastrointestinal symptoms that commonly occur with GLP-1 medications.

The clinic's telehealth-exclusive model provides scheduling flexibility for Las Vegas residents balancing work schedules, family obligations, or mobility limitations that make traditional office visits challenging. We Do Care Weight Loss does not operate physical examination facilities, which means patients requiring in-person diagnostic testing, body composition analysis, or hands-on medical assessment will need to coordinate those services separately with local providers. The practice focuses specifically on the prescription management and nutritional counseling components of weight loss rather than comprehensive metabolic testing or surgical weight loss referrals. This streamlined approach serves patients seeking medication-assisted weight management with the convenience of virtual care delivery throughout Nevada.